Revenue Dynamics YoY (Last Twelve Months): ginkgobioworks.com (DNA)

Ginkgo Bioworks Holdings (DNA) business is moderately cyclical, as long-term deals with industry behemoths offset the reduction in IT spending by startups. The 12-month trailing sales dynamics compared to the same period last year visualize these trends, where the -44.70 mark indicates the current valuation level. The company is considered a synthetic biology visionary that has earned the trust of governments. Research continuity is ensured through the diversification of rare bio-component suppliers.
ginkgobioworks.com (DNA) - metric breakdowns and financial figures

This indicator measures the relative revenue dynamics over a rolling year, allowing for an assessment of business scaling rates compared to the same period last year. By analyzing the trend of sales changes year-over-year over a 12-month period, an investor can see the correlation between the revenue growth of Ginkgo Bioworks Holdings (DNA) and the volume of investments from biopharmaceutical partners into the launch of new synthetic biology programs.